Polymeric nanoparticles for cancer therapy

References

• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro- and nanoparticles in drug delivery. J Control Release 2004; 100: 5–28
   PubMed Web of Science ®Google Scholar
• Akerman ME, Chan WC, Laakkonen P, Bhatia SN, Ruoslahti E. Nanocrystal targeting in vivo. Proc Natl Acad Sci USA 2002; 99: 12617–12621
   PubMed Web of Science ®Google Scholar
• Arangoa MA, Duzgunes N, Tros de Ilarduya C. Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes. Gene Ther 2003; 10: 5–14
   PubMed Web of Science ®Google Scholar
• Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 2006; 17: 247–289
   PubMed Web of Science ®Google Scholar
• Au JL, Jang SH, Zheng J, Chen CT, Song S, Hu L, Wientjes MG. Determinants of drug delivery and transport to solid tumors. J Control Release 2001; 74: 31–46
   PubMed Web of Science ®Google Scholar
• Bae KH, Lee Y, Park TG. Oil-encapsulating PEO–PPO–PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel. Biomacromolecules 2007; 8: 650–656
   PubMed Web of Science ®Google Scholar
• Banerjee HN, Verma M. Use of nanotechnology for the development of novel cancer biomarkers. Expert Rev Mol Diagn 2006; 6: 679–683
   PubMed Web of Science ®Google Scholar
• Banks WA, Kastin AJ. Characterization of lectin-mediated brain uptake of HIV-1 GP120. J Neurosci Res 1998; 54: 522–529
   PubMed Web of Science ®Google Scholar
• Bies C, Lehr CM, Woodley JF. Lectin-mediated drug targeting: History and applications. Adv Drug Deliv Rev 2004; 56: 425–435
   PubMed Web of Science ®Google Scholar
• Bodnar M, Hartmann JF, Borbely J. Preparation and characterization of chitosan-based nanoparticles. Biomacromolecules 2005; 6: 2521–2527
   PubMed Web of Science ®Google Scholar
• Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev 2004; 56: 1649–1659
   PubMed Web of Science ®Google Scholar
• Burgstaller P, Jenne A, Blind M. Aptamers and aptazymes: Accelerating small molecule drug discovery. Curr Opin Drug Discov Devel 2002; 5: 690–700
   PubMed Web of Science ®Google Scholar
• Chan WC, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotechnol 2002; 13: 40–46
   PubMed Web of Science ®Google Scholar
• Cho YW, Park SA, Han TH, Son DH, Park JS, Oh SJ, Moon DH, Cho KJ, Ahn CH, Byun Y, Kim IS, Kwon IC, Kim SY. In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: Mechanisms, key factors, and their implications. Biomaterials 2007; 28: 1236–1247
   PubMed Web of Science ®Google Scholar
• Damascelli B, Cantu G, Mattavelli F, Tamplenizza P, Bidoli P, Leo E, Dosio F, Cerrotta AM, Di Tolla G, Frigerio LF, Garbagnati F, Lanocita R, Marchiano A, Patelli G, Spreafico C, Ticha V, Vespro V, Zunino F. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): Phase II study of patients with squamous cell carcinoma of the head and neck and anal canal: Preliminary evidence of clinical activity. Cancer 2001; 92: 2592–2602
   PubMed Web of Science ®Google Scholar
• Daniels TR, Delgado T, Helguera G, Penichet ML. The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells. Clin Immunol 2006a; 121: 159–176
   PubMed Web of Science ®Google Scholar
• Daniels TR, Delgado T, Rodriguez JA, Helguera G, Penichet ML. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006b; 121: 144–158
   PubMed Web of Science ®Google Scholar
• De Mejia EG, Prisecaru VI. Lectins as bioactive plant proteins: A potential in cancer treatment. Crit Rev Food Sci Nutr 2005; 45: 425–445
   PubMed Web of Science ®Google Scholar
• Dellian M, Witwer BP, Salehi HA, Yuan F, Jain RK. Quantitation and physiological characterization of angiogenic vessels in mice: Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 1996; 149: 59–71
   PubMed Web of Science ®Google Scholar
• Devalapally H, Duan Z, Seiden MV, Amiji MM. Paclitaxel and ceramide co-administration in biodegradable polymeric nanoparticulate delivery system to overcome drug resistance in ovarian cancer. Int J Cancer 2007; 121: 1830–1880
   PubMed Web of Science ®Google Scholar
• Dodane V, Vivivalam VD. Pharmaceutical applications of chitosan. Pharm Sci Technol Today 1998; 1: 246–253
   Google Scholar
• Dreis S, Rothweiler F, Michaelis M, Cinatl J, Jr., Kreuter J, Langer K. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int J Pharm 2007; 341: 207–214
   PubMed Web of Science ®Google Scholar
• Drolet DW, Nelson J, Tucker CE, Zack PM, Nixon K, Bolin R, Judkins MB, Farmer JA, Wolf JL, Gill SC, Bendele RA. Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeys. Pharm Res 2000; 17: 1503–1510
   PubMed Web of Science ®Google Scholar
• Ellington AD, Szostak JW. In vitro selection of RNA molecules that bind specific ligands. Nature 1990; 346: 818–822
   PubMed Web of Science ®Google Scholar
• Emerich DF, Thanos CG. Nanotechnology and medicine. Expert Opin Biol Ther 2003; 3: 655–663
   PubMed Web of Science ®Google Scholar
• Faisant N, Siepmann J, Benoit JP. PLGA-based microparticles: Elucidation of mechanisms and a new, simple mathematical model quantifying drug release. Eur J Pharm Sci 2002; 15: 355–366
   PubMed Web of Science ®Google Scholar
• Fang J, Sawa T, Maeda H. Factors and mechanism of “EPR” effect and the enhanced anti-tumor effects of macromolecular drugs including SMANCS. Adv Exp Med Biol 2003; 519: 29–49
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Cheng J, Teply BA, Sherifi I, Jon S, Kantoff PW, Richie JP, Langer R. Targeted nanoparticle–aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci USA 2006a; 103: 6315–6320
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Karp JM, Langer R. Nanoparticle–aptamer bioconjugates for cancer targeting. Expert Opin Drug Deliv 2006b; 3: 311–324
   PubMed Web of Science ®Google Scholar
• Feng SS. Nanoparticles of biodegradable polymers for new-concept chemotherapy. Expert Rev Med Devices 2004; 1: 115–125
   PubMed Web of Science ®Google Scholar
• Feng SS, Chien S. Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem Engr Sci 2003; 58: 4087–4114
   Web of Science ®Google Scholar
• Fischer D, Kissel T. Histochemical characterization of primary capillary endothelial cells from porcine brains using monoclonal antibodies and fluorescein isothiocyanate-labelled lectins: Implications for drug delivery. Eur J Pharm Biopharm 2001; 52: 1–11
   PubMed Web of Science ®Google Scholar
• Fonsatti E, Altomonte M, Arslan P, Maio M. Endoglin (CD105): A target for anti-angiogenetic cancer therapy. Curr Drug Targets 2003; 4: 291–296
   PubMed Web of Science ®Google Scholar
• Fontana G, Maniscalco L, Schillaci D, Cavallaro G, Giammona G. Solid lipid nanoparticles containing tamoxifen characterization and in vitro antitumoral activity. Drug Deliv 2005; 12: 385–392
   PubMed Web of Science ®Google Scholar
• Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004; 22: 969–976
   PubMed Web of Science ®Google Scholar
• Greish K, Fang J, Inutsuka T, Nagamitsu A, Maeda H. Macromolecular therapeutics: Advantages and prospects with special emphasis on solid tumour targeting. Clin Pharmacokinet 2003; 42: 1089–1105
   PubMed Web of Science ®Google Scholar
• Grodzinski P, Silver M, Molnar LK. Nanotechnology for cancer diagnostics: Promises and challenges. Expert Rev Mol Diagn 2006; 6: 307–318
   PubMed Web of Science ®Google Scholar
• Gryparis EC, Hatziapostolou M, Papadimitriou E, Avgoustakis K. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. Eur J Pharm Biopharm 2007; 67: 1–8
   PubMed Web of Science ®Google Scholar
• Gupta Y, Jain A, Jain SK. Transferrin-conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain. J Am Chem Soc 2005; 127: 11364–11371
   PubMedGoogle Scholar
• Hicke BJ, Stephens AW. Escort aptamers: A delivery service for diagnosis and therapy. J Clin Invest 2000; 106: 923–928
   PubMed Web of Science ®Google Scholar
• Hilgenbrink AR, Low PS. Folate receptor-mediated drug targeting: From therapeutics to diagnostics. J Pharm Sci 2005; 94: 2135–2146
   PubMed Web of Science ®Google Scholar
• Hoshino A, Hanaki K, Suzuki K, Yamamoto K. Applications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse body. Biochem Biophys Res Commun 2004; 314: 46–53
   PubMed Web of Science ®Google Scholar
• Hsi RA, Rosenthal DI, Glatstein E. Photodynamic therapy in the treatment of cancer: Current state of the art. Drugs 1999; 57: 725–734
   PubMed Web of Science ®Google Scholar
• Hyung Park J, Kwon S, Lee M, Chung H, Kim JH, Kim YS, Park RW, Kim IS, Bong Seo S, Kwon IC, Young Jeong S. Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: In vivo biodistribution and anti-tumor activity. Biomaterials 2006; 27: 119–126
   PubMed Web of Science ®Google Scholar
• Ibrahim NK, Desai N, Legha S, Soon-Shiong P, Theriault RL, Rivera E, Esmaeli B, Ring SE, Bedikian A, Hortobagyi GN, Ellerhorst JA. Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res 2002; 8: 1038–1044
   PubMed Web of Science ®Google Scholar
• Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1998; 15: 1326–1331
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000; 21: 2475–2490
   PubMed Web of Science ®Google Scholar
• Jeong YI, Seo SJ, Park IK, Lee HC, Kang IC, Akaike T, Cho CS. Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(gamma-benzyl l-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. Int J Pharm 2005; 296: 151–161
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim YS, Kim S, Park JH, Kim K, Choi K, Chung H, Jeong SY, Park RW, Kim IS, Kwon IC. Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel. J Control Release 2006; 111: 228–234
   PubMed Web of Science ®Google Scholar
• Kirpotin DB, Drummond DC, Shao Y, Shalaby MR, Hong K, Nielsen UB, Marks JD, Benz CC, Park JW. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res 2006; 66: 6732–6740
   PubMed Web of Science ®Google Scholar
• Koziara JM, Lockman PR, Allen DD, Mumper RJ. Paclitaxel nanoparticles for the potential treatment of brain tumors. J Control Release 2004; 99: 259–269
   PubMed Web of Science ®Google Scholar
• Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP, Balogh LP, Khan MK, Baker JRJ. Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 2005; 65: 5317–5324
   PubMed Web of Science ®Google Scholar
• Kumagai M, Imai Y, Nakamura T, Yamasaki Y, Sekino M, Ueno S, Hanaoka K, Kikuchi K, Nagano T, Kaneko E, Shimokado K, Kataoka K. Iron hydroxide nanoparticles coated with poly(ethylene glycol)-poly(aspartic acid) block copolymer as novel magnetic resonance contrast agents for in vivo cancer imaging. Colloids Surf B Biointerfaces 2007; 56: 174–181
   PubMed Web of Science ®Google Scholar
• Labhasetwar V. Nanoparticles for drug delivery. Pharm News 1997; 4: 28–31
   Google Scholar
• Labhasetwar V, Song C, Levy RJ. Nanoparticle drug delivery for restinosis. Adv Drug Del Rev 1997; 24: 63–85
   Web of Science ®Google Scholar
• Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM. Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 2001; 299: 775–781
   PubMed Web of Science ®Google Scholar
• Lee S, Perez-Luna VH. Dextran–gold nanoparticle hybrid material for biomolecule immobilization and detection. Anal Chem 2005; 77: 7204–7211
   PubMed Web of Science ®Google Scholar
• Lee MK, Lim SJ, Kim CK. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 2007; 28: 2137–2146
   PubMed Web of Science ®Google Scholar
• Lian W, Litherland SA, Badrane H, Tan W, Wu D, Baker HV, Gulig PA, Lim DV, Jin S. Ultrasensitive detection of biomolecules with fluorescent dye-doped nanoparticles. Anal Biochem 2004; 334: 135–144
   PubMed Web of Science ®Google Scholar
• Lin R, Shi Ng L, Wang CH. In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 2005; 26: 4476–4485
   PubMed Web of Science ®Google Scholar
• Liu SQ, Wiradharma N, Gao SJ, Tong YW, Yang YY. Bio-functional micelles self-assembled from a folate-conjugated block copolymer for targeted intracellular delivery of anticancer drugs. Biomaterials 2007; 28: 1423–1433
   PubMed Web of Science ®Google Scholar
• Lu Y, Low PS. Folate-mediated delivery of macromolecular anticancer therapeutic agents. Adv Drug Deliv Rev 2002; 54: 675–693
   PubMed Web of Science ®Google Scholar
• Luo Y, Prestwich GD. Cancer-targeted polymeric drugs. Curr Cancer Drug Targets 2002; 2: 209–226
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: A review. J Control Release 2000; 65: 271–284
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent SMANCS. Cancer Res 1986; 46: 6387–6392
   PubMed Web of Science ®Google Scholar
• McCaughan JS, Jr. Photodynamic therapy: A review. Drugs Aging 1999; 15: 49–68
   PubMed Web of Science ®Google Scholar
• Michalet X, Pinaud FF, Bentolila LA, Tsay JM, Doose S, Li JJ, Sundaresan G, Wu AM, Gambhir SS, Weiss S. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005; 307: 538–544
   PubMed Web of Science ®Google Scholar
• Mo Y, Lim LY. Preparation and in vitro anticancer activity of WGA-conjugated PLGA nanoparticles loaded with paclitaxel and isopropyl myristate. J Control Release 2005; 107: 30–42
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol Rev 2001; 53: 283–318
   PubMed Web of Science ®Google Scholar
• Nie S, Xing Y, Kim GJ, Simons JW. Nanotechnology applications in cancer. Annu Rev Biomed Eng 2007; 9: 257–288
   PubMed Web of Science ®Google Scholar
• Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. J Control Release 2004; 95: 613–626
   PubMed Web of Science ®Google Scholar
• Palumbo G. Photodynamic therapy and cancer: A brief sightseeing tour. Expert Opin Drug Deliv 2007; 4: 131–148
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329–347
   PubMed Web of Science ®Google Scholar
• Park TG. Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition. Biomaterials 1995; 16: 1123–1130
   PubMed Web of Science ®Google Scholar
• Parveen S, Sahoo SK. Nanomedicine: Clinical applications of polyethylene glycol conjugated proteins and drugs. Clin Pharmacokinet 2006; 45: 965–988
   PubMed Web of Science ®Google Scholar
• Peng W, Anderson DG, Bao Y, Padera RF, Jr., Langer R, Sawicki JA. Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors. Prostate 2007; 67: 855–862
   PubMed Web of Science ®Google Scholar
• Pestourie C, Tavitian B, Duconge F. Aptamers against extracellular targets for in vivo applications. Biochimie 2005; 87: 921–930
   PubMed Web of Science ®Google Scholar
• Polakovic M, Gorner T, Gref R, Dellacherie E. Lidocaine loaded biodegradable nanospheres. II Modelling of drug release. J Control Release 1999; 60: 169–177
   PubMed Web of Science ®Google Scholar
• Qi LF, Xu ZR, Li Y, Jiang X, Han XY. In vitro effects of chitosan nanoparticles on proliferation of human gastric carcinoma cell line MGC803 cells. World J Gastroenterol 2005; 11: 5136–5141
   PubMed Web of Science ®Google Scholar
• Qi L, Xu Z, Chen M. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 2007; 43: 184–193
   PubMed Web of Science ®Google Scholar
• Ricci-Junior E, Marchetti JM. Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J Microencapsul 2006; 23: 523–538
   PubMed Web of Science ®Google Scholar
• Sahoo SK. Applications of nanomedicine. Asia Pacific Biotech News 2005; 9: 1048–1050
   Google Scholar
• Sahoo SK, Labhasetwar V. Nanotech approaches to drug delivery and imaging. Drug Discov Today 2003; 8: 1112–1120
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol Pharm 2005; 2: 373–383
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Ma W, Labhasetwar V. Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer 2004; 112: 335–340
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Parveen S, Panda JJ. The present and future of nanotechnology in human health care. Nanomedicine 2007; 3: 20–31
   PubMed Web of Science ®Google Scholar
• Scherer F, Anton M, Schillinger U, Henke J, Bergemann C, Kruger A, Gansbacher B, Plank C. Magnetofection: Enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther 2002; 9: 102–109
   PubMed Web of Science ®Google Scholar
• Serpe L, Guido M, Canaparo R, Muntoni E, Cavalli R, Panzanelli P, Della Pepal C, Bargoni A, Mauro A, Gasco MR, Eandi M, Zara GP. Intracellular accumulation and cytotoxicity of doxorubicin with different pharmaceutical formulations in human cancer cell lines. J Nanosci Nanotechnol 2006; 6: 3062–3069
   PubMed Web of Science ®Google Scholar
• Sharon N. Lectins: Carbohydrate-specific reagents and biological recognition molecules. J Biol Chem 2007; 282: 2753–2764
   PubMed Web of Science ®Google Scholar
• Shenoy DB, Amiji MM. Poly(ethylene oxide)-modified poly(epsilon–caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 2005; 293: 261–270
   PubMed Web of Science ®Google Scholar
• Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28: 5–24
   PubMed Web of Science ®Google Scholar
• Shi X, Wang S, Meshinchi S, Van Antwerp ME, Bi X, Lee I, Baker JR, Jr. Dendrimer-entrapped gold nanoparticles as a platform for cancer-cell targeting and imaging. Small 2007; 7: 1245–1252
   Google Scholar
• Sibata CH, Colussi VC, Oleinick NL, Kinsella TJ. Photodynamic therapy in oncology. Expert Opin Pharmacother 2001; 2: 917–927
   PubMedGoogle Scholar
• Sinha R, Kim GJ, Nie S, Shin DM. Nanotechnology in cancer therapeutics: Bioconjugated nanoparticles for drug delivery. Mol Cancer Ther 2006; 5: 1909–1917
   PubMed Web of Science ®Google Scholar
• Solbrig CM, Saucier-Sawyer JK, Cody V, Saltzman WM, Hanlon DJ. Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells. Mol Pharm 2007; 4: 47–57
   PubMed Web of Science ®Google Scholar
• Steiniger SC, Kreuter J, Khalansky AS, Skidan IN, Bobruskin AI, Smirnova ZS, Severin SE, Uhl R, Kock M, Geiger KD, Gelperina SE. Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles. Int J Cancer 2004; 109: 759–767
   PubMed Web of Science ®Google Scholar
• Stinchcombe TE, Socinski MA, Walko CM, O'Neil BH, Collichio FA, Ivanova A, Mu H, Hawkins MJ, Goldberg RM, Lindley C, Claire Dees E. Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (abraxane(R)) on three treatment schedules in patients with solid tumors. Cancer Chemother Pharmacol 2007; 60: 759–766
   PubMed Web of Science ®Google Scholar
• Thorpe PE. Vascular targeting agents as cancer therapeutics. Clin Cancer Res 2004; 10: 415–427
   PubMed Web of Science ®Google Scholar
• Tiyaboonchai W. Chitosan nanoparticles: A promising system for drug delivery. Naesuan Univ J 2003; 11: 51–66
   Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005; 4: 145–160
   PubMed Web of Science ®Google Scholar
• Tsutsui Y, Tomizawa K, Nagita M, Michiue H, Nishiki T, Ohmori I, Seno M, Matsui H. Development of bionanocapsules targeting brain tumors. J Control Release 2007; 122: 159–164
   PubMed Web of Science ®Google Scholar
• Tuerk C, Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990; 249: 505–510
   PubMed Web of Science ®Google Scholar
• Vasir JK, Labhasetwar V. Targeted drug delivery in cancer therapy. Technol Cancer Res Treat 2005; 4: 363–374
   PubMed Web of Science ®Google Scholar
• Wang N, Wu XS, Li C, Feng MF. Synthesis, characterization, biodegradation, and drug delivery application of biodegradable lactic/glycolic acid polymers: I. Synthesis and characterization. J Biomater Sci Polym Ed 2000; 11: 301–318
   PubMed Web of Science ®Google Scholar
• Wang HZ, Wang HY, Liang RQ, Ruan KC. Detection of tumor marker CA125 in ovarian carcinoma using quantum dots. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 681–686
   PubMed Web of Science ®Google Scholar
• Wang MD, Shin DM, Simons JW, Nie S. Nanotechnology for targeted cancer therapy. Expert Rev Anticancer Ther 2007; 7: 833–837
   PubMed Web of Science ®Google Scholar
• Weiner LM. Fully human therapeutic monoclonal antibodies. J Immunother 2006; 29: 1–9
   PubMed Web of Science ®Google Scholar
• White RR, Sullenger BA, Rusconi CP. Developing aptamers into therapeutics. J Clin Invest 2000; 106: 929–934
   PubMed Web of Science ®Google Scholar
• Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 2004; 56: 1257–1272
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev 2007a; 59: 491–504
   PubMed Web of Science ®Google Scholar
• Wong HL, Rauth AM, Bendayan R, Wu XY. In vivo evaluation of a new polymer–lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Eur J Pharm Biopharm 2007b; 65: 300–308
   PubMed Web of Science ®Google Scholar
• Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm 2003; 250: 215–226
   PubMed Web of Science ®Google Scholar
• Xu Z, Gu W, Huang J, Sui H, Zhou Z, Yang Y, Yan Z, Li Y. In vitro and in vivo evaluation of actively targetable nanoparticles for paclitaxel delivery. Int J Pharm 2005; 288: 361–368
   PubMed Web of Science ®Google Scholar
• Yemisci M, Bozdag S, Cetin M, Soylemezoglu F, Capan Y, Dalkara T, Vural I. Treatment of malignant gliomas with mitoxantrone-loaded poly (lactide-co-glycolide) microspheres. Neurosurgery 2006; 59: 1296–1302, discussion 1302–1293
   PubMed Web of Science ®Google Scholar
• Yoo HS, Park TG. Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 2004; 96: 273–283
   PubMed Web of Science ®Google Scholar
• Zeisser-Labouebe M, Lange N, Gurny R, Delie F. Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer. Int J Pharm 2006; 326: 174–181
   PubMed Web of Science ®Google Scholar
• Zhang Z, Feng SS. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 2006; 27: 4025–4033
   PubMed Web of Science ®Google Scholar
• Zhang Z, Huey LS, Feng SS. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS NPs for targeted drug delivery. Biomaterials 2007; 28: 1889–1899
   PubMed Web of Science ®Google Scholar
• zur Muhlen A, Schwarz C, Mehnert W. Solid lipid nanoparticles (SLN) for controlled drug delivery–drug release and release mechanism. Eur J Pharm Biopharm 1998; 45: 149–155
   PubMed Web of Science ®Google Scholar